Recombinant multi-species ATR/FRP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATR/FRP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]
The Alternative Names of target: ATR,Ataxia telangiectasia and Rad3-related protein,Atr,FCTCS,FRAP-related protein 1,FRP1,MEC1,SCKL,SCKL1,Serine/threonine-protein kinase ATR
Go
to ATR/FRP1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0060-Ag-1/ GM-Tg-hg-IP0060-Ag-2 | Human ATR/FRP1 protein | Human |
| GM-Tg-rg-IP0060-Ag-1/ GM-Tg-rg-IP0060-Ag-2 | Rat ATR/FRP1 protein | Rat |
| GM-Tg-mg-IP0060-Ag-1/ GM-Tg-mg-IP0060-Ag-2 | Mouse ATR/FRP1 protein | Mouse |
| GM-Tg-cynog-IP0060-Ag-1/ GM-Tg-cynog-IP0060-Ag-2 | Cynomolgus/Rhesus macaque ATR/FRP1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0060-Ag-1/ GM-Tg-felg-IP0060-Ag-2 | Feline ATR/FRP1 protein | Feline |
| GM-Tg-cang-IP0060-Ag-1/ GM-Tg-cang-IP0060-Ag-2 | Canine ATR/FRP1 protein | Canine |
| GM-Tg-bovg-IP0060-Ag-1/ GM-Tg-bovg-IP0060-Ag-2 | Bovine ATR/FRP1 protein | Bovine |
| GM-Tg-equg-IP0060-Ag-1/ GM-Tg-equg-IP0060-Ag-2 | Equine ATR/FRP1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0060-Ag-1/ GM-Tg-hg-IP0060-Ag-2;
GM-Tg-rg-IP0060-Ag-1/ GM-Tg-rg-IP0060-Ag-2;
GM-Tg-mg-IP0060-Ag-1/ GM-Tg-mg-IP0060-Ag-2; GM-Tg-cynog-IP0060-Ag-1/ GM-Tg-cynog-IP0060-Ag-2; GM-Tg-felg-IP0060-Ag-1/ GM-Tg-felg-IP0060-Ag-2; GM-Tg-cang-IP0060-Ag-1/ GM-Tg-cang-IP0060-Ag-2; GM-Tg-bovg-IP0060-Ag-1/ GM-Tg-bovg-IP0060-Ag-2; GM-Tg-equg-IP0060-Ag-1/ GM-Tg-equg-IP0060-Ag-2 |
| Products Name | ATR/FRP1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ATR/FRP1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATR/FRP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.